Not Signed In -
Lactose Intolerance |
Lactose Intolerence |
Clinical Trial: Prevalence of Lactose Intolerance Following Stem Cell Transplantation.
This study is not yet open for patient recruitment.
Verified by University of British Columbia October 2005
|
Purpose
It is currently assumed that all patients are lactose intolerant post bone marrow transplantation. This pilot study is to assess what the incidence of lactose intolerance is after bone marrow transplantation in children. This will be done using a lactose breath test.
| Condition | Phase |
|---|---|
| Lactose Intolerance | Phase I |
MedlinePlus related topics: Lactose Intolerance
Study Type: Observational
Study Design: Screening, Cross-Sectional, Defined Population, Prospective Study
Official Title: Prevalence of Lactose Intolerance Following Stem Cell Transplantation in Pediatric Patients.
Further study details as provided by University of British Columbia:
Expected Total Enrollment: 20
Study start: October 2005; Expected completion: February 2007
Last follow-up: October 2006; Data entry closure: December 2006
All pediatric patients over the age of 4 years who are scheduled for a stem cell transplant will be approached to assess whether what the incidence of lactose intolerance is in the post transplant period and how quickly recovery occurs. A baseline lactose and lactulose breath test will be performed followed by repeat lactose breath tests starting 2 weeks after day 0 and repeated every fortnight for 10 weeks. Stool pH and reducing substances will be checked at the time of the breath tests to see if there is any correlation.
Eligibility
Ages Eligible for Study: 4 Years - 18 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
All patients planned to undergo a stem cell transplant.
Exclusion Criteria:
refusal to participate, Unable to perform breath tests on request (generally under the age of 4 years.).
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier NCT00247806
Colin C Barker cbarker@cw.bc.ca
Canada, British Columbia
BC Children’s Hospital, Vancouver, British Columbia, V6H 3V4, Canada
Colin C Barker, PhD cbarker@cw.bc.ca
Colin C Barker, PhD, Principal Investigator
Colin C Barker, PhD, Principal Investigator
Study chairs or principal investigators
Colin Barker, PhD, Principal Investigator, University of British Columbia
More Information
Study ID Numbers: C05-0180
Last Updated: December 8, 2005
Record first received: October 31, 2005
ClinicalTrials.gov Identifier: NCT00247806
Health Authority: Canada: Health Canada
ClinicalTrials.gov processed this record on 2006-01-10
Last Updated: December 8, 2005
Record first received: October 31, 2005
ClinicalTrials.gov Identifier: NCT00247806
Health Authority: Canada: Health Canada
ClinicalTrials.gov processed this record on 2006-01-10
email this page
print this page
bookmark this page
feedback on this page
